Biomedical Engineering Reference
In-Depth Information
-
How should pharmaceutical fi rms shape their alliance portfolio management
approach to be receptive to a changing environment; in the case of the pharma-
ceutical industry, to address scientifi c developments beyond biopharmaceuticals
such as nanotechnology, the promise of personalized medicine, and healthcare
reforms? This approach requires a stronger institutional embedding of alliance
portfolio studies than we have witnessed thus far.
References
Aggarwal RK, Samwick AA (2003) Why do managers diversify their fi rms? Agency reconsidered.
J Finance 58(1):71-118
Ahuja G, Lampert CM (2001) Entrepreneurship in the large corporation: a longitudinal study of
how established fi rms create breakthrough inventions. Strateg Manage J 22(6/7):521-543
Ansoff HI (1958) A model for diversifi cation. Manage Sci 4(4):392-414
Argyres N (1996) Capabilities, technological diversifi cation and divisionalization. Strateg Manage
J 17(5):395-410
Arora A, Gambardella A (1994) Evaluating technological information and utilizing it: scientifi c
knowledge, technological capability, and external linkages in biotechnology. J Econ Behav
Organ 24(1):91-114
Aspinall MG, Hamermesh RG (2007) Realizing the promise of personalized medicine. Harv Bus
Rev 85(10):108
Bamford J, Ernst D (2002) Managing an alliance portfolio. McKinsey Q 3:29-39
Baum JAC, Calabrese T, Silverman BS (2000) Don't go it alone: alliance network composition and
startups' performance in Canadian biotechnology. Strateg Manage J 21(3):267-294
Burt RS (1992) Structural holes: the social structure of competition. Harvard University Press,
Cambridge
Capon N, Glazer R (1987) Marketing and technology: a strategic coalignment. J Market
51(3):1-14
Caves RD (1981) Diversifi cation and seller concentration: evidence from change, 1963-1972. Rev
Econ Stat 63:289-293
Chatterjee S, Lubatkin MH, Schulze MS (1999) Toward a strategic theory of risk premium: moving
beyond CAPM. Acad Manage Rev 24(3):556-567
Clark KB, Fujimoto T (1991) Product development performance: strategy, organization, and man-
agement in the world auto industry. Harvard Business School Press, Boston
Cohen WM, Levinthal DA (1990) Absorptive capacity: a new perspective on learning and innova-
tion. Adm Sci Q 35(1):128-152
Cui AS (2013) Portfolio dynamics and alliance termination: the contingent role of resource
dissimilarity. J Market 77(3):15-32
Cui AS, O'Connor G (2012) Alliance portfolio resource diversity and fi rm innovation. J Market
76(4):24-43
DiMaggio P (1992) Nadel's paradox revisited: relational and cultural aspects of organizational
structures. In: Nohria N, Eccles R (eds) Networks and organization: structure, form, and action.
Harvard Business School Press, Boston
Development.aspx
. Consulted June 2013
Ellison SF, Cockburn I, Griliches Z, Hausman J (1997) Characteristics of demand for pharmaceuti-
cal products: an examination of four cephalosporins. Rand J Econ 28(3):426-446
Fleming L (2001) Recombinant uncertainty in technological search. Manage Sci 47(1):117-132
Search WWH ::
Custom Search